Dr. Strunc is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Childrens LN
Norfolk, VA 23507Phone+1 757-668-9466Fax+1 757-668-7784
Summary
- Board-certified in child neurology and sleep medicine, with clinical emphasis in sleep notably disorders of hypersomnia. Active research in narcolepsy, and clinical chief pediatrics for sleep medicine fellowship, adult neurology residency through EVMS/ODU.
Education & Training
- Duke University HospitalFellowship, Sleep Medicine, 2008 - 2009
- The Childrens Hospital Denver COFellowship, Adult and Child Neurology, 1999 - 2002
- Naval Medical Center (San Diego)Residency, Pediatrics, 1992 - 1995
- Saint Louis University School of MedicineClass of 1992
Certifications & Licensure
- VA State Medical License 2012 - 2026
- NC State Medical License 2022 - 2025
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Sleep Medicine
Clinical Trials
- A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy Start of enrollment: 2019 Sep 21
- Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy Start of enrollment: 2021 Nov 08
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsLong-Term Treatment of Narcolepsy and Idiopathic Hypersomnia with Low-Sodium Oxybate.Logan D Schneider, Anne Marie Morse, Michael J Strunc, Joyce K Lee-Iannotti, Richard K Bogan
Nature and Science of Sleep. 2023-01-01 - 8 citationsDevelopment and Validation of the Pediatric Hypersomnolence Survey.Kiran Maski, Jennifer Worhach, Erin Steinhart, Madeline Boduch, Anne Marie Morse
Neurology. 2022-05-10 - 8 citationsThe Xyrem ® (Sodium Oxybate) Risk Evaluation and Mitigation Strategy (REMS) Program in the USA: Results From 2016 to 2017Michael J Strunc, Jed Black, Prasheel Lillaney, Judi Profant, Sherice Mills
Drugs - Real World Outcomes. 2021-01-13
Press Mentions
- Neurologic Nuggets of Wisdom for Pediatric PracticeOctober 27th, 2023
- Dancing Through a Difficult Diagnosis: A Girl’s Journey with ADEMOctober 14th, 2021
- Getting the Kids Back on a School Sleep RoutineAugust 27th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: